| Product Code: ETC8190958 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Malta continues to see a significant influx of drug-device combination products through import shipments, with key exporting countries including India, Israel, Ireland, Germany, and Belgium in 2024. The market shows sustained concentration with a high Herfindahl-Hirschman Index (HHI) in the same year. The compound annual growth rate (CAGR) from 2020 to 2024 stands at a healthy 10.1%, indicating a stable upward trend. Moreover, the impressive growth rate of 29.61% from 2023 to 2024 suggests a dynamic market environment with opportunities for further expansion and innovation in drug-device combination products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Drug-Device Combination Products Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Drug-Device Combination Products Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Malta Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Malta Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Malta Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Malta Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Malta Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Malta leading to the need for innovative treatment solutions. |
4.2.2 Growing adoption of drug-device combination products due to their convenience and effectiveness. |
4.2.3 Favorable government regulations supporting the development and commercialization of such products. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-device combination products leading to longer time-to-market. |
4.3.2 High development costs and investment required for research and development of these complex products. |
5 Malta Drug-Device Combination Products Market Trends |
6 Malta Drug-Device Combination Products Market, By Types |
6.1 Malta Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malta Drug-Device Combination Products Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Malta Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2021- 2031F |
6.1.4 Malta Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2021- 2031F |
6.1.5 Malta Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2021- 2031F |
6.1.6 Malta Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2021- 2031F |
6.1.7 Malta Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.8 Malta Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2021- 2031F |
6.1.9 Malta Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.1.10 Malta Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Malta Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malta Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.2.3 Malta Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.2.4 Malta Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2021- 2031F |
6.2.5 Malta Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2021- 2031F |
6.2.6 Malta Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2021- 2031F |
6.2.7 Malta Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Malta Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Malta Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2021- 2031F |
6.3.3 Malta Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2021- 2031F |
6.3.4 Malta Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2021- 2031F |
6.3.5 Malta Drug-Device Combination Products Market Revenues & Volume, By Other, 2021- 2031F |
7 Malta Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Malta Drug-Device Combination Products Market Export to Major Countries |
7.2 Malta Drug-Device Combination Products Market Imports from Major Countries |
8 Malta Drug-Device Combination Products Market Key Performance Indicators |
8.1 Number of patents filed for drug-device combination products in Malta. |
8.2 Investment in research and development of new drug-device combination products. |
8.3 Number of clinical trials conducted for drug-device combination products in Malta. |
9 Malta Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Malta Drug-Device Combination Products Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Malta Drug-Device Combination Products Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Malta Drug-Device Combination Products Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Malta Drug-Device Combination Products Market - Competitive Landscape |
10.1 Malta Drug-Device Combination Products Market Revenue Share, By Companies, 2024 |
10.2 Malta Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here